On July 15, 2021, the corner stone laying ceremony of Qide Building, the second biopark of YHLO,  was grandly held in Baolong Street, Longgang District, Shenzhen.

Located next to the first YHLO Biopark, the brand new YHLO Biopark II covers an area of 18,010.18 square meters and has a total construction area of nearly 110,000 square meters, which expected to be completed in April 2024. The park will construct 3 new buildings, along with the first park founded in 2018 and Wisdow Plaza office in Nanshan District, the full equipped facilities will assist YHLO people to run faster on the way to become the world leading IVD company.

The name of Qide Building, ‘Qi’ and ‘De’ come from The Classic of Poetry and TaoTeChing of ancient China, which stand for initiative and morality. That means YHLO is about to open up new territory and fields in IVD industry world-wide. Meanwhile, YHLO would develop with high morality, better serve our customers and giving back to the society.

To be a reliable and respected IVD enterprise, YHLO has put extensive investments in R&D and firmly associated with the top-tier universities, medical schools and research institutes worldwide on scientific studies. With over a decade's continuous development expertise in immunoassays solution, YHLO provides a broad range of instruments (based on Chemiluminescence, ELISA, Immunoblot and Immunofluorescence methodologies) with patented technologies and outstanding features, as well as a comprehensive total solutions with portfolios in fertility and reproductive health, diabetes, infectious diseases, autoimmune disorders and other novel assays on rare diseases analysis. Since the Covid-19 pandemic outbreak, YHLO has taken a fast response and launched series of assays to assist people around the world in large scale screening test.

YHLO would develope advanced technologies and create more medical value for health and vitality of people all over the world!